Record Information |
---|
Version | 2.0 |
---|
Created at | 2005-11-16 15:48:42 UTC |
---|
Updated at | 2021-10-07 20:39:51 UTC |
---|
NP-MRD ID | NP0001141 |
---|
Secondary Accession Numbers | None |
---|
Natural Product Identification |
---|
Common Name | Levulinic acid |
---|
Description | Levulinic acid is a crystalline keto acid prepared from levulose, inulin, starch, etc., By boiling them with dilute hydrochloric or sulfuric acids. |
---|
Structure | InChI=1S/C5H8O3/c1-4(6)2-3-5(7)8/h2-3H2,1H3,(H,7,8) |
---|
Synonyms | Value | Source |
---|
3-Acetylpropionic acid | ChEBI | 3-Ketobutane-1-carboxylic acid | ChEBI | 4-Ketovaleric acid | ChEBI | 4-Oxovaleric acid | ChEBI | beta-Acetylpropionic acid | ChEBI | gamma-Ketovaleric acid | ChEBI | LAEVULINIC ACID | ChEBI | Laevulinsaeure | ChEBI | LEVA | ChEBI | Levulic acid | ChEBI | Levulinsaeure | ChEBI | 3-Acetylpropionate | Generator | 3-Ketobutane-1-carboxylate | Generator | 4-Ketovalerate | Generator | 4-Oxovalerate | Generator | b-Acetylpropionate | Generator | b-Acetylpropionic acid | Generator | beta-Acetylpropionate | Generator | Β-acetylpropionate | Generator | Β-acetylpropionic acid | Generator | g-Ketovalerate | Generator | g-Ketovaleric acid | Generator | gamma-Ketovalerate | Generator | Γ-ketovalerate | Generator | Γ-ketovaleric acid | Generator | LAEVULINate | Generator | Levulate | Generator | Levulinate | Generator | 4-Oxopentanoate | HMDB | 4-Oxopentanoic acid | HMDB | Diasporal | HMDB | Levulinic acid, sodium salt | HMDB | Magnesium diasporal | HMDB | Calcium levulate | HMDB | Magnesium levulinate | HMDB | Calcium levulinate | HMDB | Levulinic acid, ammonium salt | HMDB | Levulinic acid, calcium salt | HMDB | Magnesium laevulinate | HMDB | Levulinic acid | ChEBI | 4-Oxopentanoic acid, 4-ketovaleric acid | MeSH |
|
---|
Chemical Formula | C5H8O3 |
---|
Average Mass | 116.1152 Da |
---|
Monoisotopic Mass | 116.04734 Da |
---|
IUPAC Name | 4-oxopentanoic acid |
---|
Traditional Name | levulinic acid |
---|
CAS Registry Number | 123-76-2 |
---|
SMILES | CC(=O)CCC(O)=O |
---|
InChI Identifier | InChI=1S/C5H8O3/c1-4(6)2-3-5(7)8/h2-3H2,1H3,(H,7,8) |
---|
InChI Key | JOOXCMJARBKPKM-UHFFFAOYSA-N |
---|
Experimental Spectra |
---|
|
| Spectrum Type | Description | Depositor Email | Depositor Organization | Depositor | Deposition Date | View |
---|
1D NMR | 1H NMR Spectrum (1D, 500 MHz, H2O, experimental) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 2D NMR | [1H, 13C]-HSQC NMR Spectrum (2D, 600 MHz, H2O, experimental) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum |
| Predicted Spectra |
---|
|
| Not Available | Chemical Shift Submissions |
---|
|
| Not Available | Species |
---|
Species of Origin | |
---|
Species Where Detected | |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as gamma-keto acids and derivatives. These are organic compounds containing an aldehyde substituted with a keto group on the C4 carbon atom. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organic acids and derivatives |
---|
Class | Keto acids and derivatives |
---|
Sub Class | Gamma-keto acids and derivatives |
---|
Direct Parent | Gamma-keto acids and derivatives |
---|
Alternative Parents | |
---|
Substituents | - Gamma-keto acid
- Short-chain keto acid
- Ketone
- Monocarboxylic acid or derivatives
- Carboxylic acid
- Carboxylic acid derivative
- Organic oxygen compound
- Organic oxide
- Hydrocarbon derivative
- Organooxygen compound
- Carbonyl group
- Aliphatic acyclic compound
|
---|
Molecular Framework | Aliphatic acyclic compounds |
---|
External Descriptors | |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Properties | |
---|
Predicted Properties | |
---|
General References | - Ohdoi C, Nyhan WL, Kuhara T: Chemical diagnosis of Lesch-Nyhan syndrome using gas chromatography-mass spectrometry detection. J Chromatogr B Analyt Technol Biomed Life Sci. 2003 Jul 15;792(1):123-30. [PubMed:12829005 ]
- Lopez Montes A, Lorenzo I, Perez Martinez J: [Porphyria and inappropriate antidiuretic hormone syndrome]. Nefrologia. 2004;24 Suppl 3:85-8. [PubMed:15219077 ]
- Melgaard B, Clausen J, Rastogi SC: Heavy metal levels and delta-amino-levulinic acid dehydrase levels in peripheral polyneuropathy. Acta Neurol Scand. 1976 Apr;53(4):291-307. [PubMed:178141 ]
- Matsui M, Kaji R, Oka N, Nishio T, Kimura J: [Multifocal axonal motor neuropathy associated with anti-ganglioside antibodies]. Rinsho Shinkeigaku. 1992 Oct;32(10):1130-5. [PubMed:1297559 ]
- Keithly L, Ferris Wayne G, Cullen DM, Connolly GN: Industry research on the use and effects of levulinic acid: a case study in cigarette additives. Nicotine Tob Res. 2005 Oct;7(5):761-71. [PubMed:16191747 ]
- Endo G, Horiguchi S, Kiyota I: Urinary N-acetyl-beta-D-glucosaminidase activity in lead-exposed workers. J Appl Toxicol. 1990 Aug;10(4):235-8. [PubMed:2391405 ]
|
---|